Home › Blog

first_aid_kit-namespace  ·  2026-11-04  ·  ~60 min read

Arsine (AsH₃) poisoning in semiconductor manufacturing: the invisible hematological trap — RBC oxidative hemolysis, Heinz bodies, hemoglobinuria 2–24h, and why the standard first aid kit addresses none of it

Most industrial toxic gases kill by asphyxiating the lung or corroding the airway. Arsine kills by destroying red blood cells — with no respiratory symptoms whatsoever. Workers feel fine, leave the building, and pass burgundy-red urine 12 hours later while sleeping. The correct first_aid_kit.* namespace: arsine_source, rbc_destruction_mechanism=oxidative_hemolysis, exchange_transfusion_risk=true, renal_failure_risk=true, detector_required=arsine_specific_electrochemical.

1. Arsine in semiconductor manufacturing: why GaAs reactor maintenance is the highest-risk scenario

Arsine (AsH₃, arsenic trihydride) is the simplest arsenic hydride — a colorless, flammable gas with an odor described variously as "garlic," "fish," or "mild unpleasant" at concentrations below the IDLH. The odor threshold (0.5–1.0 ppm) is above the ACGIH TLV (0.005 ppm) by a factor of 100–200, making odor an entirely unreliable warning signal. Workers can sustain a hemolytically significant exposure with no sensory warning whatsoever.

In semiconductor manufacturing, arsine serves as the primary n-type dopant source for III-V compound semiconductor epitaxy. The critical applications:

• MOCVD (metalorganic chemical vapor deposition): GaAs, GaAlAs, InGaAsP, and InP epitaxial layer growth for high-electron-mobility transistors (HEMTs), heterojunction bipolar transistors (HBTs), solar cells, and laser diodes. AsH₃ at 10–100% cylinder purity is delivered through mass flow controllers into the reactor at process temperatures of 500–750°C, where it cracks to liberate elemental arsenic (As(s)) and H₂. Any breach in the gas delivery line — cracked fitting, failed valve seat, mass flow controller leak during maintenance — releases AsH₃ at cylinder pressure.
• MBE (molecular beam epitaxy): Arsenic effusion cells use solid arsenic, but arsine is used in gas-source MBE (GSMBE) and metalorganic MBE variants. The AsH₃ cracking zone inside the MBE chamber can generate As vapor that migrates to any opened chamber port.
• Dopant cylinder changeout: High-pressure specialty gas cylinders of AsH₃ in hydrogen or nitrogen diluent (1%, 5%, 10%, 100% grades) must be purged, disconnected, and replaced under procedures that specify double block-and-bleed isolation. A single procedure deviation — opening the cylinder valve before the downstream block valve is confirmed shut — releases gas into the face of the cylinder changeout technician at flow rates of 1–5 SLPM before the valve is closed.
• Reactor decommissioning and maintenance openings: After AsH₃ processing, internal reactor surfaces are coated with elemental arsenic (As(s)) and arsenic compounds. When these surfaces contact moisture from the atmosphere during maintenance openings, chemical reduction can generate AsH₃ in situ: 2As(s) + 3H₂O → As₂O₃ + 3H₂ → (with nascent H) → AsH₃. This mechanism is slower but can sustain low-level AsH₃ exposure throughout the duration of a maintenance window.

The 4-gas monitor failure

The single most dangerous gap in arsine hazard management is the near-universal deployment of standard 4-gas personal monitors — LEL/O₂/CO/H₂S — in industrial settings. These four sensors are chosen for the four most common hazards in confined spaces and industrial atmospheres generally. Arsine is not among them. A worker with a fully functional, properly calibrated 4-gas monitor enters a GaAs reactor maintenance area during a cylinder changeout incident and is exposed to 2 ppm AsH₃. All four sensors read normal. The gas alarm does not sound. The worker completes their task and leaves the area with no documented exposure event. Twelve hours later, the hemolysis that began within 90 minutes of that exposure has destroyed a substantial fraction of circulating RBCs.

Arsine-specific detection requires an electrochemical sensor designed and calibrated for AsH₃. These sensors are commercially available from major industrial hygiene instrument manufacturers (Draeger, Industrial Scientific, MSA) and are physically identical in size and form factor to standard 4-gas monitor sensor inserts. The installation cost per monitor is under $200. The absence of these sensors from compound semiconductor fab personal monitors is a process safety gap that has contributed to documented arsine fatalities in semiconductor facilities. Semiconductor Safety Association (SSA) guidelines and SEMI S2 (Safety Guideline for Semiconductor Manufacturing Equipment) both specify arsine-specific sensing for MOCVD areas, but legacy monitor fleets often predate these specifications.

2. Mechanism: why arsine destroys red blood cells instead of lung tissue

The molecular basis for arsine's unique hematological toxicity lies in the physicochemical interaction between arsenic-containing reactive species and the erythrocyte's biochemical environment. The mechanism is distinct from arsenic trioxide (As₂O₃) or arsenate (AsO₄³⁻) poisoning and cannot be assumed to follow the same treatment logic.

Step 1: AsH₃ enters the RBC and depletes glutathione

Arsine crosses biological membranes freely due to its small molecular size (MW 77.95) and near-zero polarity. It penetrates erythrocyte membranes without specific transport protein involvement. Once inside the RBC, AsH₃ encounters the cell's primary antioxidant defense: reduced glutathione (GSH), maintained at 2–3 mM by the hexose monophosphate shunt (glucose-6-phosphate dehydrogenase → NADPH → glutathione reductase → GSH). Arsine undergoes oxidation in the presence of oxyhemoglobin to generate dihydroxyarsine (AsH(OH)₂) and other reactive arsenic intermediates that oxidize GSH to GSSG (glutathione disulfide) through a cycle that is not easily reversed. Within 60–90 minutes of a significant arsine dose, the RBC's GSH pool is depleted below the threshold needed to protect hemoglobin and membrane lipids from oxidative damage.

Step 2: Hemoglobin oxidation and Heinz body formation

With GSH depleted, arsine-generated oxidative intermediates attack hemoglobin directly. Oxyhemoglobin (HbO₂) is converted to methemoglobin (MetHb), which then undergoes irreversible denaturation and precipitation within the RBC as inclusion bodies — the classic Heinz bodies (named for Robert Heinz, who described them in phenylhydrazine poisoning in 1890). Heinz bodies are clusters of denatured hemoglobin chains attached to the inner leaflet of the RBC membrane. They are visible on supravital staining with crystal violet or brilliant cresyl blue but not on standard Wright-Giemsa peripheral blood smear preparations — a critical diagnostic pitfall, since the smear ordered urgently in an ED may appear normal even as massive hemolysis proceeds.

Step 3: RBC destruction — two pathways

Hemolysis in arsine poisoning proceeds by two simultaneous mechanisms:

Extravascular hemolysis: Heinz bodies attached to the RBC membrane create surface irregularities that splenic macrophages recognize as "eat me" signals. The spleen attempts to strip Heinz bodies from passing RBCs ("pitting") — a process that removes chunks of RBC membrane, reducing the cell to a spherocyte with reduced deformability that is then trapped and destroyed in the splenic cords. This produces the classic fragmented RBC (schistocyte) and spherocyte morphology visible on subsequent blood smears as hemolysis peaks.

Intravascular hemolysis: At higher arsine doses, membrane lipid peroxidation directly disrupts the RBC bilayer, causing osmotic lysis within the circulation. Free hemoglobin is released directly into plasma, overwhelming the plasma haptoglobin binding capacity (haptoglobin saturates at approximately 0.5–1.5 g/L free Hb) and appearing as pink plasma (hemoglobinemia). Free hemoglobin is filtered at the glomerulus — the threshold for hemoglobinuria is approximately 150–300 mg/dL plasma free hemoglobin — producing the characteristic pink-to-dark-burgundy urine that is the pathognomonic sign of significant arsine exposure.

The timing trap: why workers appear well at first

The lag between arsine inhalation and clinical hemolysis is a function of the GSH depletion and RBC destruction timeline. The sequence:

The critical period is 0–4 hours: the worker is completely asymptomatic. Standard first aid protocol (remove from exposure, give oxygen, observe briefly, discharge if asymptomatic) sends a worker who has sustained a hematologically significant exposure home without IV access, baseline labs, or urine monitoring. When symptoms develop — 6–12 hours later, often in the middle of the night — the worker may not connect their dark urine to the "minor gas exposure" at work. Some cases have presented to EDs the following morning with hemoglobin already below 5 g/dL, in impending renal failure.

3. Renal failure mechanism: heme pigment nephrotoxicity

The acute kidney injury (AKI) in arsine poisoning results from several converging mechanisms, all stemming from the hemolytic event:

Tubular heme pigment precipitation: Free hemoglobin filtered at the glomerulus dissociates in the collecting duct and proximal tubule into αβ dimers, which further dissociate into free heme (iron-protoporphyrin IX). At urine pH below 5.5–6.0, heme precipitates as brown granular casts that physically obstruct tubular flow — the pathological correlate of "muddy brown casts" on urinalysis microscopy. Alkalinization of the urine (pH >6.5) keeps heme dissociated and excreted, which is the biochemical rationale for the sodium bicarbonate infusion used in treatment.

Direct heme nephrotoxicity: Free heme is a potent vasoconstrictor of the afferent arteriole through its action as a nitric oxide scavenger (heme + NO → nitrosylhemoglobin, depleting local NO and causing renal vasoconstriction). This reduces glomerular filtration rate independent of tubular obstruction. Additionally, heme undergoes Fenton-type chemistry in the renal tubular epithelium, generating hydroxyl radicals that directly injure tubular cell mitochondria, triggering apoptosis.

Hemolytic anemia cardiovascular sequelae: A sudden fall in hemoglobin from, say, 14 g/dL to 5 g/dL reduces blood oxygen-carrying capacity by 64%. The compensatory response — increased cardiac output — raises renal vascular pressure transiently but cannot sustain adequate renal perfusion in the context of a vasoconstricted renal microvasculature. Oliguric AKI from prerenal azotemia compounds the intrinsic heme-mediated tubular injury.

AKI severity classification in arsine poisoning

4. Treatment: what must happen in the first 24 hours

There is no antidote for arsine poisoning. No chelating agent, no enzyme activator, no receptor antagonist reverses the hemolytic process once it is underway. Treatment is entirely supportive and aimed at three goals: (1) preventing further hemolysis by removing the worker from exposure, (2) protecting the kidneys from heme pigment injury while hemolysis continues, and (3) replacing oxygen-carrying capacity with packed RBCs or exchange transfusion in severe cases.

Immediate measures (scene and transport)

Remove from exposure immediately. Every additional minute in the arsine atmosphere increases the AsH₃ body burden distributed to circulating RBCs. Standard self-contained breathing apparatus (SCBA) entry and removal of the worker is first priority. The worker should not ambulate under their own power after confirmed or suspected exposure above 0.1 ppm — physical exertion increases cardiac output, which increases tissue arsenic delivery.

High-flow oxygen by non-rebreather mask (10–15 L/min) has limited direct benefit for the hemolytic process — the problem is not oxygen delivery to the lung but oxygen-carrying capacity of RBCs. However, maximizing inspired oxygen fraction supports whatever oxygen-carrying capacity remains in unaffected RBCs and reduces the work of the cardiovascular compensatory response.

Mandatory ED transport — no exceptions. Arsine exposure cannot be triaged as "observe at home." The pathophysiology is invisible at the time of exposure. By the time symptoms appear, significant hemolysis has already occurred. Every worker with confirmed arsine exposure (above the action level of approximately 0.025 ppm, confirmed by air monitoring or strong circumstantial evidence) requires IV placement, baseline labs, and at minimum 6–8 hours of observed urinalysis monitoring in a medical setting.

Baseline labs — the arsine panel

The first lab draw should be obtained as early as possible — ideally before the first dose of IV fluids, since dilution reduces sensitivity of early markers:

• CBC with differential and reticulocyte count — baseline hemoglobin, serial monitoring. Reticulocytes will be low initially (the bone marrow has not yet responded) — a "normal" reticulocyte count in the context of falling hemoglobin confirms acute destructive hemolysis rather than production failure.
• Peripheral blood smear — specifically request Heinz body staining (supravital stain with crystal violet or brilliant cresyl blue). Standard Wright-Giemsa smear will appear normal in early hemolysis. Heinz bodies require supravital preparation.
• Plasma free hemoglobin — pink-tinged plasma (hemoglobinemia) is visible at concentrations above approximately 50 mg/dL. Lab quantification confirms intravascular hemolysis and provides a severity indicator.
• Haptoglobin — will be low or undetectable once hemolysis exceeds the binding capacity (<0.1 g/L indicates significant ongoing hemolysis).
• LDH (lactate dehydrogenase) — released from lysed RBCs; elevated early in hemolysis before creatinine rises; a useful early severity marker when other hemolysis markers are borderline.
• Bilirubin (total and indirect) — indirect hyperbilirubinemia from heme catabolism to bilirubin via heme oxygenase. Peaks 12–24 hours after hemolysis peak. Jaundice (clinical icterus) requires bilirubin above approximately 2.5–3.0 mg/dL.
• BMP (basic metabolic panel) — creatinine, BUN, electrolytes, bicarbonate — baseline renal function and acid-base status before hemoglobinuric AKI develops. Hyperkalemia from RBC lysis is a specific electrolyte concern requiring monitoring.
• Urinalysis with microscopy and urine hemoglobin — pink or red urine before visible blood on dipstick (hemoglobin positive, RBC negative on microscopy) confirms hemoglobinuria vs hematuria. Granular casts on microscopy indicate established tubular injury.
• Methemoglobin level — arsine can cause methemoglobin elevation in addition to hemolysis; relevant to oxygen-carrying capacity calculation and may trigger methylene blue treatment if above 25–30%.
• Arsenic blood/urine levels — acute arsenic levels (inorganic arsenic, plasma or whole blood) confirm exposure but are not useful for immediate management decisions. Useful for medico-legal documentation and worker compensation purposes.

IV hydration and urine alkalinization

The goal is urine output of 1–2 mL/kg/h to flush heme pigment through the renal tubules before it precipitates. Typical initial rates: 250–500 mL/h isotonic crystalloid (lactated Ringer's or normal saline) for the first 2–4 hours, then adjusted to urine output response. Sodium bicarbonate is added to alkalize the urine: 1–2 ampules of sodium bicarbonate (50–100 mEq) added to each liter of D5W creates an infusion that raises urine pH toward 6.5–7.5. The clinical endpoint: urine dipstick pH ≥6.5, combined with urine output ≥1 mL/kg/h, is the target that minimizes cast formation. This combination — volume + alkalinization — is the most evidence-supported intervention for preventing hemoglobinuric AKI across all causes of significant hemolysis.

Packed RBC transfusion threshold

Standard hemoglobin transfusion thresholds (7–8 g/dL for most ICU patients) apply to arsine poisoning with one modification: the rate of hemoglobin fall matters as much as the absolute value. A hemoglobin of 7 g/dL that has been stable for 4 hours is very different from a hemoglobin of 7 g/dL that fell from 12 g/dL in 6 hours and continues to fall. Active hemolysis with continued AsH₃-laden RBCs circulating means that transfused packed RBCs will also be exposed to any residual arsenic-hemoglobin reactive species — diluting but not eliminating the ongoing destruction. Serial hemoglobins every 2–4 hours during the acute phase are essential for detecting continued hemolysis despite supportive care.

Exchange transfusion: indications and logistics

Exchange transfusion — simultaneous removal of the patient's AsH₃-damaged RBCs and arsenic-carrying plasma while replacing with donor packed RBCs and fresh frozen plasma — is the definitive treatment for severe arsine poisoning. It achieves two goals simultaneously: (1) removes the substrate for ongoing hemolysis (arsenic-laden RBCs that have not yet fully lysed but will continue to do so over the next 24–48 hours), and (2) replaces oxygen-carrying capacity with RBCs that are uncontaminated by arsenic.

Indications typically cited in the clinical literature (Armstrong et al., 1984; Wilkinson et al., 1991; Hirata et al., 1998):

• Hemoglobin below 5 g/dL, especially with active hemolysis and evidence of cardiovascular compromise
• Plasma arsenic level above 100 µg/L with ongoing hemolysis unresponsive to IV hydration
• Oliguric AKI developing despite aggressive IV hydration and urine alkalinization
• Severe symptomatic anemia (chest pain, ECG changes, altered mental status) at any hemoglobin level

Exchange transfusion is a procedure performed in specialized centers (typically hematology or intensive care settings with apheresis capability). The first aid kit's written protocol must include the instruction to notify the receiving hospital of suspected arsine poisoning specifically, rather than "toxic gas inhalation," because the requesting physician in the ED must know to alert hematology for potential exchange transfusion setup before the patient deteriorates to hemoglobin <5 g/dL at 2:00 AM.

What NOT to do: BAL chelation during the acute phase

British Anti-Lewisite (BAL, dimercaprol) is the classic arsenic chelating agent. The reflex to administer BAL for "arsenic poisoning" is a dangerous error in acute arsine hemolysis. BAL and arsenic form a water-soluble complex that is renally excreted — the therapeutic rationale for arsenical poisoning from arsenite (As³⁺) or arsenate (As⁵⁺). In arsine poisoning, however, the arsenic has already been incorporated into the hemoglobin and RBC membrane structure through oxidative reactions. BAL chelation does not reverse the hemolytic process, and the lipophilic nature of BAL-arsenic complexes can in some circumstances worsen RBC membrane instability. Current toxicology guidelines (UpToDate, Goldfrank's Toxicologic Emergencies) advise against BAL use in acute arsine hemolysis except in specific confirmed scenarios of mixed arsenic poisoning. DMSA (dimercaptosuccinic acid, succimer) may be used for inorganic arsenic chelation during the recovery phase after active hemolysis has resolved, primarily to accelerate elimination of residual inorganic arsenic species.

5. Exposure limits and the OSHA–ACGIH gap

The 10-fold discrepancy between OSHA's occupational exposure limit and ACGIH's threshold limit value reflects decades of updated toxicological evidence that the OSHA PEL (set in 1971) has not incorporated:

The practical implication: a facility in OSHA compliance at 0.04 ppm (just below the PEL) is operating at 8× the ACGIH TLV — a level at which hematological effects have been documented in controlled exposure studies. ACGIH's basis for the 0.005 ppm TLV is the 1980 Wilkinson and McIntosh monkey inhalation study, which demonstrated measurable RBC hemolysis at 0.025 ppm over 6 hours. Extrapolating to an 8-hour workday using an uncertainty factor of 5 gives 0.005 ppm. The ACGIH TLV is the more protective and scientifically current standard; semiconductor fabs operating under SEMI S2 safety guidelines typically adopt ACGIH TLV as the internal action level regardless of OSHA compliance status.

6. Medical surveillance in arsine-exposed workforces

Unlike some hazardous materials with 24-hour biological effect timescales, arsine-exposed workers benefit from a specific medical surveillance program that can detect subclinical hemolysis before overt clinical injury. ACGIH's BEI (Biological Exposure Index) for inorganic arsenic — 35 µg inorganic arsenic per gram creatinine in urine — applies to arsenic compound exposure generally; there is no AsH₃-specific BEI as of 2026, partly because the relationship between arsine air concentration and urinary arsenic excretion is confounded by dietary arsenic (seafood, particularly fish, can produce urinary inorganic arsenic above the BEI without occupational exposure).

The practical surveillance approach in compound semiconductor fabs:

• Pre-placement baseline CBC — establishes normal hemoglobin, hematocrit, reticulocyte count before exposure begins. Essential for interpreting future changes in context.
• Periodic CBC every 6–12 months for workers with routine AsH₃ exposure above action levels. A fall in hemoglobin of 1.5–2.0 g/dL from baseline in the absence of dietary or other explanation is a signal for enhanced air monitoring review and IH reassessment.
• Post-exposure CBC within 4 hours for any suspected arsine exposure event (triggered by air monitoring alarm, perceptible odor, or equipment malfunction in AsH₃ service). This is the specific intervention that occupational health must pre-arrange with the site's occupational medicine provider — a standing order for "post-arsine-exposure hemolysis panel" that can be executed without a physician phone triage when a worker is transported to the occupational medicine clinic.
• Spot urine arsenic as a confirmatory biomarker after suspected exposure — speciated arsenic (inorganic arsenic fraction) is preferable to total urinary arsenic to exclude dietary confounders. A reference lab 24-hour speciated urine arsenic collection is the gold standard but impractical for acute decisions; a spot urine inorganic arsenic corrected for creatinine can be reported within 2–3 hours in most clinical labs serving industrial customers.

7. The ANSI Z308.1 gap for arsine exposures

ANSI Z308.1-2021 "Minimum Requirements for Workplace First Aid Kits and Supplies" defines Class A and Class B kits by quantity of supplied materials (bandages, gauze, antiseptic, burn treatment, eye wash, cold pack, CPR shield, emergency blanket, tourniquet). Class B kits add expanded quantities and a few additional items (more trauma dressings, additional eye wash). Neither class specifies any chemical-specific antidotes, monitoring equipment, or occupational-medicine referral protocols.

For arsine exposure specifically, the ANSI Z308.1 kit addresses exactly one relevant element of a correct response: the oxygen non-rebreather mask (Class A required, 10–15 L/min). Everything else the first aid responder needs to do — establish IV access, draw the hemolysis panel, start aggressive IV hydration, alkalinize the urine, monitor serial hemoglobins, make the exchange transfusion call — requires hospital transport and is not achievable at the scene level regardless of kit contents.

The critical first aid gap is therefore not about kit contents — it is about first responder instruction. The arsine-specific first aid protocol must override the standard assessment algorithm ("is the patient alert, is respiratory function adequate, can they ambulate?") and mandate ED transport regardless of symptom status. This protocol cannot live in the ANSI kit itself; it must be in the site-specific Chemical Hygiene Plan (CHP) emergency response section, displayed at the AsH₃ gas cabinet, and trained annually to the response team. The first aid kit's role is to supply the oxygen and the written transport instruction; the protocol does the rest.

8. Case scenario walkthrough: GaAs MOCVD cylinder changeout incident

To illustrate the full timeline from exposure to outcome, consider the following reconstructed scenario (composite of documented case reports):

Setting: A 400-wafer/week GaAs MOCVD fab. A maintenance technician is performing a scheduled cylinder changeout of a 10% AsH₃/90% H₂ specialty gas cylinder (550L, size 200 cylinder, process gas for epitaxial layer doping). Standard operating procedure requires confirming the upstream mass flow controller is at zero setpoint, closing the cylinder valve, verifying zero cylinder pressure on the high-pressure gauge, connecting the purge nitrogen supply to sweep the regulator, then disconnecting the cylinder.

Deviation: During the purge step, the upstream block valve upstream of the mass flow controller is confirmed closed by the technician based on the valve position indicator, which is mechanically stuck in the "closed" position when the valve is actually partially open. The purge nitrogen backflows through the partially-open MFC, and the residual 10% AsH₃/H₂ in the cylinder regulator is swept back toward the connection point rather than forward through the purge path. The technician disconnects the regulator with approximately 0.5 psi residual line pressure, releasing a brief puff of 10% AsH₃/H₂ at close range (face-level exposure approximately 1 second at 1–3 cm distance from face).

Immediate response: The technician notices a faint garlic odor and reports it to the safety office as a "possible minor gas release." The safety officer dispatches an IH, who reads 0.02 ppm on an arsine-specific detector at the connection point (background elevated but below PEL). The technician is not wearing their SCBA (they had stored it at the other end of the lab). The safety officer assesses: technician is alert, no respiratory symptoms, no skin irritation, no eye symptoms. Standard "minor exposure" protocol: document the event, have the technician sit for 30 minutes, re-assess. Technician is re-assessed at 30 minutes — still asymptomatic. Released to continue their shift.

14 hours later: The technician wakes at 2:30 AM and passes dark red-brown urine. Thinking it is dehydration from a long shift, they drink water and return to bed. At 7:00 AM they appear for work, visibly pale. The occupational health nurse orders an emergency CBC: hemoglobin 6.1 g/dL (down from an estimated 14 g/dL baseline). Urinalysis: massive hemoglobinuria (5+ on dipstick), no red cells on microscopy, granular casts present. Creatinine 2.4 mg/dL. The technician is transported to the hospital by ambulance for IV hydration, serial monitoring, and nephrology consultation.

Outcome and what should have happened: The technician required 4 days of hospitalization, IV bicarbonate infusion, and 2 units of packed RBCs. Creatinine peaked at 3.8 mg/dL but returned to baseline over 10 days without dialysis. Full recovery. What should have happened differently: the 30-minute symptom-free observation should never have been used to make a "no transport" decision. Any arsine exposure (confirmed by AsH₃-specific sensor above 0.005 ppm, or any detectable odor at face level during a handling procedure) mandates immediate ED transport for the hemolysis panel and IV placement. The technician's normal symptom status at 30 minutes is exactly what the arsine toxicology predicts — it is not evidence of a safe exposure.

9. Arsine vs other hematological industrial hazards: the differential

Not every cause of hemoglobinuria in an industrial worker is arsine. The first responder and occupational medicine provider should consider the differential:

In a compound semiconductor fab, arsine is the overwhelming probability for a worker with hemoglobinuria and a gas handling history. Stibine is worth noting because antimony compounds are used as p-type dopant precursors in some III-V processes and can be present in the same gas delivery systems, but its clinical management is identical to arsine. Phosphine is used in the same MOCVD systems as an n-type dopant for InP and other phosphide compounds, and a co-exposure scenario (phosphine + arsine) is possible during GaAsP or InGaAsP growth; the treatment priorities do not conflict (IV hydration and urine alkalinization for arsine hemolysis; remove from phosphine; both benefit from high-flow O₂).

10. Namespace encoding: arsine in the first_aid_kit-namespace for AI shopping agents

For an AI shopping agent recommending occupational safety products to a compound semiconductor equipment supplier, chemical manufacturer, or semiconductor fab safety team, the following namespace fields in the product listing or vendor catalog enable correct product selection:

AI routing decision table: arsine first aid queries

Summary: the arsine-first-aid-kit alignment problem

Arsine poisoning represents the clearest case of a hazard whose first aid requirement is fundamentally incompatible with the ANSI Z308.1 kit-based paradigm. The standard kit addresses surface-level injury — burns, lacerations, respiratory distress. Arsine produces none of these at the scene. The worker appears well. The kit passes visual inspection as appropriate. The first responder, trained to triage by symptoms, has no signal to act on. The worker goes home. The hemolysis proceeds. The worker calls 911 from the bathroom floor 14 hours later.

The correct first aid kit for arsine-exposed environments is not a different collection of physical supplies — it is a different decision rule. Any confirmed or probable AsH₃ exposure above the action level is a mandatory ED transport regardless of symptom status. The oxygen non-rebreather, the IV access, the urine alkalinization, and the exchange transfusion threshold call happen at the hospital. The first aid kit's job is to get the worker there before the hemolysis clock expires on the kidneys.

Namespace fields that enable an AI shopping agent to route to this first aid configuration: arsine_source, rbc_destruction_mechanism=oxidative_hemolysis, exchange_transfusion_risk=true_severe, renal_failure_risk=true, antidote_type=none_iv_fluids_primary, detector_required=arsine_specific_electrochemical, bal_chelation_contraindicated_acute_phase=true.